Health Minister Hon. Leona Aglukaaq : firstname.lastname@example.org,
NDP Health Critic MP Libby Davies : email@example.com
Liberal Health Critic MP Hedy Fry: firstname.lastname@example.org
Interim Liberal Leader MP Bob Rae: RaeB@parl.gc.ca
MP Mauril Belanger (Ottawa-Vanier) : BelanM@parl.gc.ca
Dear Minister of Health, and Members of Parliament,
I'm writing to you all today to ask you to hold Clinical trials for a cancer drug (Rituximab) that has been found to alleviate the symptoms of ME/CFS patients.
In a recent study, 67% of ME/CFS patients taking the cancer drug Rituximab had the symptoms of ME/CFS alleviated and in two cases go into complete remission. You can read the study here: "Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study" (www.plosone.org/article/info:
This is a link to an article in New Scientist about the discovery. http://www.
newscientist.com/article/ dn21065-chronic-fatigue- syndrome-eased-by-cancer-drug. html
This blinded study was only done with a small number of patients, and larger studies are needed to discover its effectiveness on ME/CFS patients. ME/CFS patients are housebound, bedridden, some unable to talk, read, or write. A moment cannot be wasted to change the lives of these patients.
-There are more than 400, 000 ME/CFS patients in Canada.
- ME refers to Myalgic Encephalomyelitis and CFS refers to Chronic Fatigue Syndrome. It is widely known as ME/CFS.
-The World Health Organization classifies ME/CFS as a neurological illness at G93.3
- The cause of the disease is unknown.
- Patients lives are drastically changed by this disease as they lose jobs, homes, spouses, and family support due to the stigma of this illness.
- Patients are often too sick to care for themselves, but there is no standard treatment, no drug, and little to no economic or social support for patients with this illness.
- Patients are a great loss to the economy in lost productivity and cost of care.
- A Drug that actually treats the disease of ME/CFS is needed to treat this devastating a debilitating disease.
The company in Canada responsible for Rituximab is Hoffmann-La Roche.
I would like to call on this government and its opposition to support Clinical Trials for ME/CFS patients in Canada with Rituximab to move this important research forward in hopes that in time there could be a drug to treat ME/CFS patients.